Efficacy of Delafloxacin Versus Moxifloxacin Against Bacterial Respiratory Pathogens in Adults With Community-Acquired Bacterial Pneumonia (CABP): Microbiology Results From the Delafloxacin Phase 3 CABP Trial

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.01949-19
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology


Related search